Welcome to SentoClone AB

SentoClone AB is a Swedish innovative biotechnology company that develops a unique and patented immunotherapy to treat cancer. The immunotherapy, which is in a clinical development phase, strengthens the patient's own immune system to combat cancer without significant side effects. The company was founded in 2004 and the head office is located in Sundbyberg, where a production and research facility was built in 2008.

On this homepage there is information about the company, method and business for both the general public and for healthcare professionals.

You are on the start page for the general public. Use the tabs and headlines in the left column to navigate through the website.

If you have any questions or thoughts that you would like to share with us – click on the headline Contact us in the left column.